Keyphrases
Spain
95%
Bacterial Meningitis
83%
Adult Patients
53%
COVID-19
51%
Surgical Site Infection
51%
Epidemiology
46%
Multicenter Cohort Study
41%
Acute Bacterial Meningitis
37%
Barcelona
36%
Confidence Interval
35%
Catheter-related Bloodstream Infection (CRBSI)
34%
HIV Patients
34%
COVID-19 Patients
34%
Randomized Clinical Trial
34%
Fever
32%
Meropenem
30%
Tuberculosis
30%
Etiology
30%
Antibiotic Therapy
28%
Antibiotic Treatment
25%
Meningitis
25%
Incidence Rate
22%
Cognitive Complaints
22%
Urinary Tract Infection
22%
Gram-negative Bacilli
21%
Colorectal Surgery
21%
University Hospital
20%
Elective Colorectal Surgery
20%
Mortality Prediction
20%
Infection Rate
20%
Coagulase-negative Staphylococci (CoNS)
19%
Organ Space Surgical Site Infection
19%
Penicillium Marneffei
17%
Single Domain
17%
Post-COVID-19 Fatigue
17%
Krebs Von Den Lungen-6 (KL-6)
17%
Gold-plus
17%
16S Ribosomal DNA
17%
Neuropsychological Deficits
17%
Quorum Quenching Enzyme
17%
Quorum Sensing Network
17%
Aida
17%
High-risk Clone
17%
COVID-19 Pandemic
17%
Gram-negative Meningitis
17%
Cognitive Domains
17%
Human Herpesvirus 1
17%
Subjective Cognitive Complaints
17%
Cognitive Sequelae
17%
Post-COVID Patients
17%
Medicine and Dentistry
Infection
92%
Bacterial Meningitis
85%
Cohort Analysis
70%
COVID-19
68%
Surgical Infection
60%
Human Immunodeficiency Virus
51%
Antibiotic Therapy
45%
Bloodstream Infection
42%
Cohort Effect
38%
Prospective Cohort Study
36%
Catheter Infection
34%
Randomized Clinical Trial
34%
Colorectal Surgery
34%
QuantiFERON
34%
Infection Rate
20%
Coagulase Negative Staphylococcus
19%
Clinician
18%
Malignant Neoplasm
17%
Bacterium Culture
17%
Elderly Patient
17%
Penicilliosis
17%
Air Trapping
17%
Delayed Diagnosis
17%
Carbapenemase Producing Enterobacteriaceae
17%
Highly Active Antiretroviral Therapy
17%
DNA 16S
17%
Arthroplasty
17%
Trigeminal Neuralgia
17%
Glycoprotein
17%
Inflammatory Disorder
17%
Spontaneous Bacterial Peritonitis
17%
Meningoencephalitis
17%
Human Alphaherpesvirus 1
17%
Diagnostic Accuracy
17%
Neonatal Sepsis
17%
Postoperative Infection
17%
Pseudomonas fluorescens
17%
Chimeric Antigen Receptor T-Cell Immunotherapy
17%
Pediatrics Patient
17%
Immunity
17%
Escherichia coli
17%
Fosfomycin
17%
Urinary Tract Infection
17%
Reverse Transcription Polymerase Chain Reaction
17%
Coronary Care Unit
17%
Revertant
17%
Antiinfective Agent
17%
Treatment Duration
17%
General Surgery
17%
Ceftriaxone
14%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Bacterial Meningitis
76%
Antibiotic Therapy
44%
Meropenem
40%
Cohort Study
37%
Prospective Cohort Study
36%
Disease
36%
Coronavirinae
34%
Catheter Infection
34%
Randomized Clinical Trial
34%
Surgical Infection
34%
Meningitis
24%
Escherichia coli
23%
Ceftriaxone
22%
Urinary Tract Infection
20%
Antiinfective Agent
19%
Penicillinase
19%
HIV
19%
Infection Rate
18%
Newborn Sepsis
17%
DNA 16S
17%
Carbapenemase Producing Enterobacteriaceae
17%
Coagulase Negative Staphylococcus
17%
Glycoprotein
17%
Bacterial Peritonitis
17%
Inflammatory Disease
17%
Colistimethate
17%
Pseudomonas aeruginosa
17%
Recurrent Disease
17%
Enterobacteriaceae
17%
Chimeric Antigen Receptor
17%
Reinfection
17%
Postoperative Infection
17%
Fosfomycin
17%
Metronidazole
17%
Carbapenem Derivative
17%
Amoxicillin
17%
Piperacillin Plus Tazobactam
17%
Abdominal Infection
17%
Beta Lactam Antibiotic
17%
Clavulanic Acid
17%
Ciprofloxacin
17%
Mortality Rate
15%
Gram Negative Bacterium
13%
Bacterial DNA
11%
Observational Study
11%
Infectious Agent
9%
Comorbidity
8%
Clinical Trial
7%
Clinical Feature
7%
